1,026 experimental treatments in acute stroke. Annals of neurology. 2006;59:467-77.
1,9-Alkano-bridged 2,3,4,5-tetrahydro-1H-3-benzazepines with affinity for the alpha 2-adrenoceptor and the 5-HT1A receptor. J Med Chem. 1990;33(2):633-41.
11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Molecular and cellular endocrinology. 2004;215:45-54.
11 beta-hydroxysteroid dehydrogenase type 1 induction in the arcuate nucleus by high-fat feeding: A novel constraint to hyperphagia? Endocrinology. 2006;147:4486-95.
11 beta-hydroxysteroid dehydrogenase type 1 is a predominant 11 beta-reductase in the intact perfused rat liver. The Journal of endocrinology. 2000;165:685-92.
11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain research. Molecular brain research. 1998;61:1-10.
11 Beta-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Annals of the New York Academy of Sciences. 2003;1007:357-66.
11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Expert Opin Investig Drugs. 2008;17(4):481-96.
11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function. Neurochem Res. 2008;33(4):624-36.
11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. The Journal of steroid biochemistry and molecular biology. 1998;64:251-60.
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:6734-9.
11Beta-hydroxysteroid dehydrogenase type 1 activity in medial vestibular nucleus and cerebellum after unilateral vestibular deafferentation in the rat. Stress (Amsterdam, Netherlands). 2004;7:127-30.
11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends in endocrinology and metabolism: TEM. 2004;15:418-24.
11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease. Expert opinion on therapeutic targets. 2003;7:771-83.
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proceedings of the National Academy of Sciences of the United States of America. 1997;94:14924-9.
11Beta-hydroxysteroid dehydrogenase type 1--a role in inflammation? Mol Cell Endocrinol. 2006;248(1-2):3-8.
11beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme. 2002;34:537-44.
11Beta-hydroxysteroid dehydrogenase type 1–a role in inflammation? Molecular and cellular endocrinology. 2006;248:3-8.